Computational Analysis of Novel Drug Opportunities (CANDO)

Computational Analysis of Novel Drug Opportunities (CANDO) analyzes drug-protein interactions across proteomes to predict drug similarities, repurpose existing therapeutics, and prioritize novel chemical entities for specific indications.


Key Features:

  • Multitarget Analysis: Evaluates drugs by their interactions with multiple biological targets to capture multitarget theory and phenotypic outcomes.
  • Drug-Proteome Interaction Scoring: Implements an in-house protocol to rapidly score large numbers of drug-protein interactions and compute drug-proteome interaction signatures.
  • Benchmarking Protocols: Provides benchmarking protocols for shotgun drug discovery and repurposing to evaluate relationships between drugs and approved indications.
  • Drug Prediction via Consensus Scoring: Generates compound predictions by consensus scoring to identify compounds most similar to known therapeutics for specific conditions.
  • Support for Novel Chemical Entities: Offers tools to compare and rank novel chemical entities against existing drug-proteome interaction signatures.
  • Machine Learning Modules: Integrates machine learning modules that support benchmarking and the prediction of putative drug candidates.

Scientific Applications:

  • Large-scale drug-protein interaction analysis: Enables proteome-wide assessment of drug-target interaction patterns to inform therapeutic hypotheses.
  • Multitarget mechanism exploration: Supports investigation of multitarget effects relevant to complex or multifaceted disease mechanisms.
  • Drug repurposing: Facilitates identification of existing drugs with similarity to approved therapeutics for new indications.
  • Novel candidate prioritization: Aids ranking and selection of novel chemical entities as potential drug candidates based on interaction signatures.

Methodology:

CANDO is implemented as a Python package and uses an in-house rapid interaction scoring protocol to compute drug-proteome interaction signatures, applies consensus scoring and benchmarking protocols for prediction and evaluation, and incorporates integrated machine learning modules to support benchmarking and candidate prediction.

Topics

Details

License:
BSD-3-Clause
Tool Type:
library
Programming Languages:
Python
Added:
1/14/2020
Last Updated:
11/24/2024

Operations

Publications

Mangione W, Falls Z, Chopra G, Samudrala R. cando.py: Open source software for predictive bioanalytics of large scale drug-protein-disease data. Unknown Journal. 2019. doi:10.1101/845545.

Mangione W, Falls Z, Chopra G, Samudrala R. cando.py: Open Source Software for Predictive Bioanalytics of Large Scale Drug–Protein–Disease Data. Journal of Chemical Information and Modeling. 2020;60(9):4131-4136. doi:10.1021/acs.jcim.0c00110. PMID:32515949. PMCID:PMC8098009.

PMID: 32515949
PMCID: PMC8098009
Funding: - National Center for Advancing Translational Sciences: UL1TR001412, UL1TR002529 - National Cancer Institute: P30CA023168 - NIH Office of the Director: DP1OD006779 - U.S. National Library of Medicine: T15LM012495

Links